Biofitus vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 229,968 | 429,765 | 821,975 | 1,058,567 | 1,315,564 | 1,962,848 | 2,258,065 | 2,523,541 |
| Profit before tax | 41,850 | 117,389 | 295,361 | 352,214 | 292,416 | 436,848 | - | 510,072 |
| Net profit | 39,573 | 99,117 | 250,592 | 299,991 | 248,000 | 371,173 | 423,905 | 427,176 |
| Equity | 47,722 | 111,545 | 279,785 | 379,775 | 357,775 | 510,712 | 640,499 | 1,055,386 |
| Liabilities | 24,495 | 61,443 | 80,412 | 87,954 | 86,084 | 94,115 | 133,059 | 158,185 |
| Non-current assets | 2,300 | 5,763 | 29,008 | 28,616 | 28,961 | 60,173 | 58,985 | 535,551 |
| Current assets | 69,850 | 163,965 | 331,071 | 438,374 | 414,164 | 543,057 | 713,819 | 676,599 |
| Total assets | 72,150 | 169,728 | 360,079 | 466,990 | 443,125 | 603,230 | 772,804 | 1,212,150 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 347,133 | 477,180 | 450,053 |
| Social insurance contributions | - | - | - | - | - | 1,320 | 6,922 | 23,115 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +215.3% | +86.9% | +91.3% | +28.8% | +24.3% | +49.2% | +15.0% | +11.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 54.8% | 58.4% | 69.6% | 64.2% | 56.0% | 61.5% | 54.9% | 35.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 82.9% | 88.9% | 89.6% | 79.0% | 69.3% | 72.7% | 66.2% | 40.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 17.2% | 23.1% | 30.5% | 28.3% | 18.9% | 18.9% | 18.8% | 16.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 18.2% | 27.3% | 35.9% | 33.3% | 22.2% | 22.3% | - | 20.2% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.6 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 172,480 | 166,363 | 308,237 | 423,427 | 493,330 | 654,283 | 677,426 | 605,645 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Biofitus vaistinė - Social security debts
The company had no debts to Sodra
Biofitus vaistinė - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-02-16 | 0.11 |
| 2025-09-01 | 2025-09-03 | 101.55 |
| 2025-08-28 | 2025-08-31 | 101.37 |
| 2025-04-28 | 2025-04-28 | 34566.97 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Biofitus vaistine, UAB (code 303187387) is a Private Limited Liability Company engaged in intermediation service activities for non-specialised retail sale. In 2025, the latest financial year, revenue increased to €2.52M, up 11.8% year on year and 28.6% over two years. Net profit reached €427.2K, following €423.9K in 2024 and €371.2K in 2023, showing continued earnings growth despite a gradual margin decline from 18.9% in 2023 to 18.8% in 2024 and 16.9% in 2025. Profit before tax in 2025 was €510.1K. The balance sheet strengthened materially: total assets rose to €1.21M, equity to €1.06M, and liabilities remained modest at €158.2K. The company’s equity ratio stood at 87.1% and debt-to-equity at 0.15, indicating a low leverage profile. Asset turnover was 2.08x, ROE 40.5%, and ROA 35.2%. Revenue per employee was €630.9K and profit per employee €106.8K, suggesting strong productivity.